Literature DB >> 19515188

Esophagectomy for cancer: clinical concerns support centralizing operations within the larger hospitals.

H Fujita1, S Ozawa, H Kuwano, Y Ueda, S Hattori, T Yanagawa.   

Abstract

Esophagectomy needs experienced surgical techniques and a well-trained perioperative care team. There are now many reports that the mortality rate after esophagectomy is higher in those hospitals with a low volume of esophagectomy and/or low surgeon's volume. The purpose of this study is to decide the respective numbers of esophagectomy operations per year to define low-volume and high-volume hospitals in Japan. If medical policy aims to further reduce mortality and morbidity associated with esophagectomy, then esophagectomy operations should be further centralized, away from low-volume hospitals, into high-volume hospitals. The Japanese Association for Thoracic Surgery has accumulated the surgical outcomes from 31 380 esophagectomy operations, registered from 709 institutes during the period from 2001 to 2006. These institutes are here classified into six groups according to the number of esophagectomy operations per year as 4 or less, 5-9, 10-19, 20-39, 40-79, and 80 or more. Using a statistical model-selection procedure by information criteria, these six groups are then classified into three categories as low-volume, medium-volume, and as high-volume hospitals. Among the 31 380 patients registered, overall, 390 patients (1.2%) died within 30 days, and 1187 patients (3.8%) died during the primary hospital stay. The odds ratio of the greatest volume group to the minimum volume group was 0.307 for the 30-day mortality rate, and 0.288 for the in-hospital mortality rate. For both the 30-day mortality rate and the in-hospital mortality rate, a hospital with less than five esophagectomy operations per year was classified as a low-volume hospital. A hospital with 40 or more esophagectomy operations per year was classified as a high-volume hospital. Concerning the number of esophagectomy operations performed per year in Japan, low-volume hospitals are defined as those where esophagectomy is performed less than five times per year, and high-volume hospitals are defined as those where esophagectomy is performed 40 or more times per year. If medical policy in Japan aims to further decrease the mortality after esophagectomy, then esophagectomy operations should be limited in these identified low-volume hospitals.

Entities:  

Mesh:

Year:  2009        PMID: 19515188     DOI: 10.1111/j.1442-2050.2009.00986.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG).

Authors:  Yasumasa Nishimura; Keiichi Jingu; Satoshi Itasaka; Yoshiharu Negoro; Yuji Murakami; Katsuyuki Karasawa; Gen Kawaguchi; Fumiaki Isohashi; Masao Kobayashi; Yoshiyuki Itoh; Takuro Ariga
Journal:  Int J Clin Oncol       Date:  2015-07-16       Impact factor: 3.402

2.  Surgeon proficiency and outcomes in esophagectomy: a perspective and comment on an analysis of the Swedish Cancer Registry.

Authors:  Fred Lee; Inderpal S Sarkaria; James D Luketich
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

3.  Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey.

Authors:  Yasumasa Nishimura; Ryuta Koike; Kazuhiko Ogawa; Ryuta Sasamoto; Yuji Murakami; Yoshiyuki Itoh; Yoshiharu Negoro; Satoshi Itasaka; Toru Sakayauchi; Tetsuro Tamamoto
Journal:  Int J Clin Oncol       Date:  2011-05-25       Impact factor: 3.402

Review 4.  Supracarinal dissection of the oesophagus and lymphadenectomy by MIE.

Authors:  Harushi Osugi; Kousuke Narumiya; Kenji Kudou
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 5.  Volume-outcome relationship in surgery for esophageal malignancy: systematic review and meta-analysis 2000-2011.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Sri Thrumurthy; Donald E Low
Journal:  J Gastrointest Surg       Date:  2011-11-17       Impact factor: 3.452

6.  The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.

Authors:  Yoichiro Tsukada; Takahiro Higashi; Hideaki Shimada; Yoshinori Kikuchi; Atsuro Terahara
Journal:  Int J Clin Oncol       Date:  2017-08-09       Impact factor: 3.402

7.  The 30-day mortality and hospital mortality after chest surgery described in the annual reports published by the Japanese Association for Thoracic and Cardiovascular Surgery.

Authors:  Hidetaka Uramoto; Meinoshin Okumura; Shunsuke Endo; Fumihiro Tanaka; Hiroyasu Yokomise; Munetaka Masuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-06

8.  Mortality after esophageal and gastric cancer resection.

Authors:  Ugo Fedeli; Elena Schievano; Manola Lisiero
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

9.  Appropriateness of the institute certification system for esophageal surgeries by the Japan Esophageal Society: evaluation of survival outcomes using data from the National Database of Hospital-Based Cancer Registries in Japan.

Authors:  Satoru Motoyama; Eri Maeda; Masahiko Yano; Takushi Yasuda; Masaichi Ohira; Yuichiro Doki; Yasushi Toh; Takahiro Higashi; Hisahiro Matsubara
Journal:  Esophagus       Date:  2018-10-15       Impact factor: 4.230

10.  Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data.

Authors:  Efty P Stavrou; Robyn Ward; Sallie-Anne Pearson
Journal:  BMC Health Serv Res       Date:  2012-11-08       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.